Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
141.34
-0.21 (-0.15%)
Sep 18, 2026, 2:08 PM EDT - Market open

Insulet Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
3,0532,9012,7082,5222,3602,1992,0721,9841,8731,7811,6971,5571,4651,3681,3051,2431,1781,1421,0991,037
Revenue Growth
29.41%31.92%30.73%27.12%26.00%23.48%22.07%27.42%27.82%30.17%30.02%25.23%24.36%19.80%18.79%19.87%18.33%19.11%21.50%19.53%
Gross Profit
2,1702,0601,9401,7891,6561,5481,4461,3891,2941,2151,1601,026968.9894.3805.6838.3801.9794.3752.1700
Operating Income
515.6507.1473.8423.5393.9340.8308.9318.6274.6237.7220.1120.2115.885.357.6127.9121.9147.612669
Net Income
375.3302.8247.1246.2236.1402.2418.3420.9395.3234206.312062.90.64.616.834.644.616.8-29.5
Earnings Per Share
5.304.293.483.463.325.555.785.745.443.312.941.710.900.010.070.230.500.640.24-0.44
EPS Growth
59.41%-22.69%-39.85%-39.75%-38.92%67.46%96.55%235.68%507.10%38259.20%4338.47%645.54%80.52%-98.65%-72.37%--402.74%140.00%-

Revenue by Segment

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
US Omnipod
2,1252,0341,9201,7961,6941,5931,5091,4601,3851,3101,2511,1331,050969.7884.8799.1728.2682.3651.5610.2
International Omnipod
910.8844.8754.2682.2618560.4523.4487.8451.3426.8410.1393.9380.5366.2363358.1363.2365.4359.9356.5
Drug Delivery
18.122.534.14447.245.138.935.936.344.23630.534.532.157.586.186.794.287.470.5
Revenue (Total)
3,0542,9012,7082,5222,3602,1992,0721,9841,8731,7811,6971,5571,4651,3681,3051,2431,1781,1421,0991,017

Cash & Debt

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
534.9480.4716.1757.41,1221,283958.8902.6821751.2704.2685.4660.1620.7674.7722708.6709.6791.6857.1
Total Debt
948.41,0141,0031,0761,4551,7491,4341,4411,4331,4381,4491,4541,4341,4291,4331,4071,4121,4161,2871,286
Net Cash (Debt)
-413.5-533.6-286.6-318.2-333.8-465.5-475.4-538.6-612.1-686.6-744.6-768.5-774.2-808.4-758.1-684.7-702.9-706.6-494.9-428.8
Net Cash Growth
--------------------
Net Cash Per Share
-5.79-7.53-3.99-4.40-4.62-6.29-6.43-7.05-8.11-9.21-10.11-10.90-11.01-11.55-10.84-9.76-10.04-10.16-7.22-6.41

Cash Flow & CapEx

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
511.2619.3569.3533.5516.1406.4430.2327.9275.6232.8145.7151.2151.9133.211942.8-39.7-46.7-68.1-25.6
Capital Expenditures
-217.5-203.6-191.6-110.1-111.2-115.1-124.9-100.6-94-87.2-75.6-110.7-121.7-120.6-122.9-90.3-86.5-91.8-111.9-130.9
Free Cash Flow
293.7415.7377.7423.4404.9291.3305.3227.3181.6145.670.140.530.212.6-3.9-47.5-126.2-138.5-180-156.5
Free Cash Flow Growth
-27.46%42.70%23.71%86.27%122.96%100.07%335.52%461.24%501.33%1055.56%----------

Margins

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
71.08%71.01%71.63%70.93%70.18%70.40%69.79%70.00%69.11%68.22%68.35%65.92%66.13%65.37%61.72%67.42%68.07%69.56%68.45%67.49%
Operating Margin
16.89%17.48%17.50%16.79%16.69%15.50%14.91%16.06%14.66%13.35%12.97%7.72%7.90%6.24%4.41%10.29%10.35%12.93%11.47%6.65%
Pretax Margin
16.20%13.94%12.54%12.32%11.47%13.34%14.49%14.95%14.28%13.75%12.65%8.29%4.76%0.37%0.75%1.68%3.55%4.33%1.87%-3.03%
Profit Margin
12.29%10.44%9.12%9.76%10.01%18.29%20.19%21.22%21.11%13.14%12.16%7.71%4.29%0.04%0.35%1.35%2.94%3.91%1.53%-2.84%
FCF Margin
9.62%14.33%13.95%16.79%17.16%13.25%14.74%11.46%9.70%8.18%4.13%2.60%2.06%0.92%-0.30%-3.82%-10.71%-12.13%-16.38%-15.09%

Valuation

Fiscal QuarterQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
28.1048.7880.9288.2793.6545.8543.7838.7735.7651.2273.4492.80319.4936968.664444.57947.69436.76413.431092.27-
Forward PE
22.7633.0749.2661.7670.5362.7370.6770.5664.4956.4793.6783.53178.16240.35227.87257.58176.17210.79227.00230.39
P/FCF Ratio
35.9135.5352.9451.3354.6163.3159.9871.8077.8382.32216.14274.96665.431760.41------
PS Ratio
3.455.097.388.629.378.398.848.237.556.738.937.1513.7216.2115.6612.8112.8316.1516.7018.87